Infectious diseases
Overview
Overview
The infectious diseases program (IDP) at QUT includes the internationally recognised Chlamydia research group, which has multiple research interests covering all aspects of chlamydial disease in humans, wildlife species and livestock.
The Arbovirus group in the IDP is also widely acclaimed. It is currently running clinical trials of a world first Ross River virus vaccine, and is a major player in studying the molecular epidemiology of dengue viruses in the Asia-Pacific region with the aim of using this information to manipulate the genetic diversity of dengue viruses to control disease.
Members of the IDP are also developing state-of-the-art molecular techniques for use in rapid diagnosis of bacterial infections, for profiling of microbial species involved in wound healing and potential bacterial species associated with gastrointestinal conditions such as irritable bowel syndrome. Investigators within the IDP are also investigating how bacteria such as ureaplasma species can colonise the upper reproductive tract of women undergoing IVF, and how the presence of these bacteria may adversely affect oocyte development, assisted reproductive technology pregnancy outcomes and early neonatal development.
Research programs
- Chlamydia
- Arboviruses
- Bacterial infections
Research enquiries
Health Research Services
- Phone: 3138 8290
- Int. phone: +61 7 3138 8290
- Email: health.research@qut.edu.au
